Advanced Proteome Therapeutics Corporation
APCH.V
TSX
| 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -94.92% | -62.16% | -53.99% | -33.80% | -21.02% |
| Total Receivables | -53.55% | -- | -3.62% | 2.05% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | 4.96% | -9.68% | 42.76% | 198.91% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 0.00% | -- |
| Total Current Assets | -92.65% | -62.64% | -48.70% | -30.34% | -14.32% |
|
|
|||||
| Total Current Assets | -92.65% | -62.64% | -48.70% | -30.34% | -14.32% |
| Net Property, Plant & Equipment | -93.41% | -22.91% | -24.21% | 142.19% | 183.05% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -92.66% | -61.81% | -48.11% | -29.11% | -13.13% |
|
|
|||||
| Total Accounts Payable | -82.80% | 14.32% | 5.43% | 71.20% | 21.49% |
| Total Accrued Expenses | -98.00% | -4.25% | -3.51% | -4.37% | 0.62% |
| Short-term Debt | -94.99% | -62.75% | -70.41% | -12.70% | 79.72% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | 104.02% | 188.93% | 217.49% | 1,138.10% |
| Total Other Current Liabilities | -- | 104.02% | 188.93% | 217.49% | 1,138.10% |
| Total Current Liabilities | -94.48% | -4.27% | -4.41% | 24.58% | 53.96% |
|
|
|||||
| Total Current Liabilities | -94.48% | -4.27% | -4.41% | 24.58% | 53.96% |
| Long-Term Debt | -- | 34.81% | 25.14% | 32.29% | 4.22% |
| Short-term Debt | -94.99% | -62.75% | -70.41% | -12.70% | 79.72% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -100.00% | -- | -- | -99.15% | -88.46% |
| Total Liabilities | -95.80% | -3.19% | -42.82% | -49.70% | -46.99% |
|
|
|||||
| Common Stock & APIC | 0.95% | 0.95% | 1.63% | 1.63% | 4.36% |
| Retained Earnings | 8.78% | -4.74% | -0.56% | 3.29% | 4.25% |
| Treasury Stock & Other | -- | 0.36% | 0.28% | 9.95% | -1.09% |
| Total Common Equity | -103.01% | -69.89% | 55.07% | 453.93% | 167.12% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -103.01% | -69.89% | 55.07% | 453.93% | 167.12% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | 19.06% | 20.15% | -9.23% | -7.84% |
| Total Equity | 98.13% | -73.91% | 39.95% | 58.68% | 58.83% |
|
|
|||||